Impact of Mallinckrodt Electronic Device on Continuous Control of Tracheal Cuff Pressure
NCT ID: NCT01965821
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2013-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous control of Pcuff followed by manual control
Patients receive continuous control of cuff pressure with Mallinckrodt electronic device for 24h, followed by discontinuous control (every 8 hours) with a manual manometer for 24h.
Continuous control of Pcuff followed by manual control
continuous control of tracheal cuff pressure using an electronic device for 24 h followed by manual control of cuff pressure using a manometer
Manual control of Pcuff followed by continuous control
Patients receive the reverse sequence (manual control followed by continuous control of Pcuff)
Manual control of Pcuff followed by continuous control
24 h of manual control using a manometer followed by 24 h of continuous control using an electronic device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous control of Pcuff followed by manual control
continuous control of tracheal cuff pressure using an electronic device for 24 h followed by manual control of cuff pressure using a manometer
Manual control of Pcuff followed by continuous control
24 h of manual control using a manometer followed by 24 h of continuous control using an electronic device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Predicted duration of mechanical ventilation \> or = 48h
* Age \> or = 18 years
* signed informed consent
Exclusion Criteria
* Contraindication for enteral nutrition
* Pregnancy
* refuse to participate to the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saad NSEIR, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rouze A, De Jonckheere J, Zerimech F, Labreuche J, Parmentier-Decrucq E, Voisin B, Jaillette E, Maboudou P, Balduyck M, Nseir S. Efficiency of an electronic device in controlling tracheal cuff pressure in critically ill patients: a randomized controlled crossover study. Ann Intensive Care. 2016 Dec;6(1):93. doi: 10.1186/s13613-016-0200-2. Epub 2016 Oct 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013 A00225 40
Identifier Type: OTHER
Identifier Source: secondary_id
2012_41
Identifier Type: -
Identifier Source: org_study_id